Combination osimertinib plus selpercatinib for EGFR-mutant non-small cell lung cancer (NSCLC) with acquired RET fusions Meeting Abstract
| Authors: | Rotow, J.; Patel, J.; Hanley, M.; Yu, H.; Goldman, J.; Nechustan, H.; Scheffler, M.; Awad, M.; Clifford, S.; Santucci, A.; Silva, L.; Tupper, R.; Oxnard, G.; Kherani, J.; Drilon, A. |
| Abstract Title: | Combination osimertinib plus selpercatinib for EGFR-mutant non-small cell lung cancer (NSCLC) with acquired RET fusions |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | nsclc; egfr-mutant; ret-mutant |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S230 |
| Language: | English |
| ACCESSION: | WOS:000631349600301 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.150 |
| Notes: | Meeting Abstract: FP14.07 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
